William Shatynski
Plus aucun poste en cours
Profil
Mr. William Shatynski is Senior Director-Financial Reporting & Controller at Edge Therapeutics, Inc.
Mr. Shatynski was previously employed as Controller & Senior Director by Transave, Inc., a Principal by ABB Power Generation Ltd., a Principal by Automatic Data Processing, Inc., a Principal by CSAV, Inc., and a Principal by Ernst & Young LLP.
He received his undergraduate degree from Rutgers University (New Jersey) and an MBA from Seton Hall University.
Anciens postes connus de William Shatynski
| Sociétés | Poste | Fin |
|---|---|---|
Transave, Inc.
 Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Comptroller/Controller/Auditor | 30/08/2012 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Comptroller/Controller/Auditor | - |
Ernst & Young LLP (Missouri)
 Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Corporate Officer/Principal | - |
| Automatic Data Processing, Inc. /Employer Services Division / | Corporate Officer/Principal | - |
Newbold Power Generation Ltd.
 Newbold Power Generation Ltd. Electrical ProductsProducer Manufacturing Newbold Power Generation Ltd. supplies power to gas combined cycle and co-generation markets. The company is based in Wallsend, UK. | Corporate Officer/Principal | - |
Formation de William Shatynski
| Rutgers State University of New Jersey | Undergraduate Degree |
| Seton Hall University | Masters Business Admin |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Health Technology |
CSAV, Inc.
 CSAV, Inc. Electronics/AppliancesConsumer Durables CSAV, Inc. designs, manufactures, markets and distributes audio visual mounting equipment. The firm’s products include flat panel display and projector mounting equipment, AV furniture, speaker stands, other AV products and accessories. The company is headquartered in Savage, MN. | Consumer Durables |
Newbold Power Generation Ltd.
Newbold Power Generation Ltd. Electrical ProductsProducer Manufacturing Newbold Power Generation Ltd. supplies power to gas combined cycle and co-generation markets. The company is based in Wallsend, UK. | Producer Manufacturing |
| Automatic Data Processing, Inc. /Employer Services Division / | Commercial Services |
Ernst & Young LLP (Missouri)
Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Ernst & Young provides accounting services. Its services include auditing, accounting, tax and transaction services, assurance and advisory business, online transaction advisory and a wide range of financial services. The company was founded by Arthur Young and Alwin C. Ernst in 1881 and is headquartered in Kansas City, MO. | Commercial Services |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
